Dr. David Benjamin Greenberg, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Ms. Madhurima Anne, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Dr. William A Lerner, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Arthur A Topilow, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Dr. Peter J Mencel, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Dr. Carl T Henningson Jr., M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 Fax: 732-528-0764 |
Dr. Michael Joshua Levitt, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1707 Atlantic Ave, Manasquan, NJ 08736 Phone: 732-528-0760 |
News Archive
New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.
Dr. Richard A. McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia at Augusta University, has received a $12.8 million grant to continue to lead a national research initiative focused on reducing the complications of diabetes.
"South Korea on Tuesday authorized the World Health Organization [WHO] to resume distribution of Seoul-funded medical aid to North Korea, amid growing calls for humanitarian assistance for malnourished North Korean children," the New York Times reports.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
While more research is needed to confirm the findings published today in the FASEB Journal, the use of FITR could herald a fast and easy way to spot early signs of infection, cancer, and difficult to diagnose neurological conditions.
› Verified 9 days ago